Elucidation of Arctigenin Pharmacokinetics and Tissue Distribution after Intravenous, Oral, Hypodermic and Sublingual Administration in Rats and Beagle Dogs: Integration of In Vitro and In Vivo Findings
Although arctigenin (AG) has diverse bioactivities, such as anti-oxidant, anti-inflammatory, anti-cancer, immunoregulatory and neuroprotective activities, its pharmacokinetics have not been systematically evaluated. The purpose of this work was to identify the pharmacokinetic properties of AG via va...
Main Authors: | Jie Li, Xin Li, Yu-Shan Ren, Yuan-Yuan Lv, Jun-Sheng Zhang, Xiao-Li Xu, Xian-Zhen Wang, Jing-Chun Yao, Gui-Min Zhang, Zhong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00376/full |
Similar Items
-
28-Day Oral Chronic Toxicity Study of Arctigenin in Rats
by: Yu-jun Tan, et al.
Published: (2018-09-01) -
Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs
by: Jie Li, et al.
Published: (2019-10-01) -
Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
by: Ying Sun, et al.
Published: (2018-03-01) -
Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation
by: Heng Li, et al.
Published: (2021-11-01) -
Pharmacokinetics of Arctigenin and Fructus Arctii Powder in Piglets
by: Bin He, et al.
Published: (2019-07-01)